On December 16, 2025, Nukkleus Inc. held a special meeting where shareholders approved several proposals, including acquiring 100% of Star Capital for cash and stock, and issuing over 3.19 million shares of common stock through warrants at an exercise price of $5.405. The approval votes were overwhelmingly positive, with approximately 99% support for each proposal.